Biopharmaceutical company Otonomy is now trading on Nasdaq.

Intel-backed Bright Lifecare, the operator of online drug store Healthkart, is in talks to raise $30m in series C funding to open two stores in Delhi.

Blood diagnostics company Seventh Sense Biosystems has raised $16m in a series B round that increased its overall equity funding to $26m.

Queensland's Appian Medical has secured about half the funding it is seeking in a $1m seed round.

IdInvest-backed biotech company Prosensa has entered into a strategic partnership with nonprofit organisation CureDuchenne following a $7m investment.

The Novartis-backed prostate cancer drug developer has filed for an initial public offering after raising more than $100m in funding.

Figure 1 has closed its series A at $4m.

University of Miami spin-out RxMP receives funding from the Institute for Commercialisation of Public Research.

Its total funding now stands at nearly $310m.

Johnson & Johnson-backed ViaCyte raised $5.4m through a sale of series C-1 preferred stock, with proceeds to fund development of its diabetes treatment.